HCA Healthcare, Inc. $HCA Stake Cut by Te Ahumairangi Investment Management Ltd

Key Points

• Te Ahumairangi Investment Management Ltd decreased its stake in HCA Healthcare, Inc. by 7.1%, now holding 19,414 shares valued at $6.7 million.
• HCA Healthcare's quarterly earnings exceeded expectations with an EPS of $6.84, and revenue of $18.61 billion, representing a 6.4% year-over-year increase.
• The company recently announced a quarterly dividend of $0.72 per share, reflecting a 0.7% yield and a low dividend payout ratio of 12.11%.

Te Ahumairangi Investment Management Ltd reduced its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 7.1% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 19,414 shares of the company's stock after selling 1,493 shares during the quarter. HCA Healthcare comprises about 1.4% of Te Ahumairangi Investment Management Ltd's holdings, making the stock its 18th largest position. Te Ahumairangi Investment Management Ltd's holdings in HCA Healthcare were worth $6,709,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in HCA. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter worth $1,021,000. Kapitalo Investimentos Ltda purchased a new stake in shares of HCA Healthcare during the 4th quarter worth $147,000. Darsana Capital Partners LP boosted its position in shares of HCA Healthcare by 6.5% in the 4th quarter. Darsana Capital Partners LP now owns 1,225,000 shares of the company's stock worth $367,684,000 after buying an additional 75,000 shares in the last quarter. Aptus Capital Advisors LLC boosted its position in shares of HCA Healthcare by 1,093.7% in the 4th quarter. Aptus Capital Advisors LLC now owns 27,228 shares of the company's stock worth $8,172,000 after buying an additional 24,947 shares in the last quarter. Finally, Alteri Wealth LLC purchased a new stake in shares of HCA Healthcare in the 4th quarter worth about $430,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

HCA has been the topic of several recent research reports. Truist Financial boosted their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research report on Wednesday, July 16th. Barclays decreased their price objective on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a research report on Monday, July 28th. Bank of America cut shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price target on the stock. in a research note on Wednesday, July 16th. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Finally, Wolfe Research lowered shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $401.83.

HCA Healthcare Stock Down 0.8%

HCA traded down $3.17 on Monday, reaching $404.11. The company's stock had a trading volume of 996,401 shares, compared to its average volume of 1,110,551. The business's 50 day moving average is $376.92 and its 200 day moving average is $357.19. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The stock has a market cap of $94.56 billion, a price-to-earnings ratio of 16.99, a price-to-earnings-growth ratio of 1.27 and a beta of 1.41. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter last year, the company earned $5.50 earnings per share. The business's quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.